Literature DB >> 445395

Gluconeogenesis from alanine in patients with progressive malignant disease.

C Waterhouse, N Jeanpretre, J Keilson.   

Abstract

We have studied by tracer technique the conversion of the carbon skeleton of alanine to glucose in patients with progressive malignant disease. These data have been compared to similar studies done in patients with chronic undernutrition from other causes. The results show increased conversion of alanine to glucose in the overnight fasting state as compared to the control group. Whereas the percentage increases are comparable to those found with pyruvate-glucose cycling in such subjects, the total amount of carbon conversion is considerably less (alanine carbon, 5.6 mmol/hr, versus pyruvate carbon, 39 mmol/hr). Exogenous glucose resulted in good suppression of alanine-to-glucose conversion as it does in normal subjects. It did, however, result in increased glucose-to-alanine conversion, increased alanine levels, and increased flux of alanine from the circulation. Although these latter data may not have specificity for the patient with advanced cancer, a strong dependence for carbohydrate and protein metabolism is suggested. We conclude that uncontrolled gluconeogenesis from alanine is probably not significant in terms of energy expenditure in the patient with uncontrolled cancer.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 445395

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

Review 1.  Metabolic alteration in patients with cancer: nutritional implications.

Authors:  Y Sakurai; S Klein
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients.

Authors:  C Drott; G Svaninger; K Lundholm
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

3.  Inhibitory effect of tumor necrosis factor α on gluconeogenesis in perfused rat liver.

Authors:  Aline Franco da Rocha; Thaís Fernanda Liboni; Carolina Campos Lima Moreira; Daniele Romani Miksza; Camila Oliveira de Souza; Flaviane de Fatima Silva; Glaucia Regina Borba-Murad; Roberto Barbosa Bazotte; Helenir Medri de Souza
Journal:  Mol Cell Biochem       Date:  2012-12-09       Impact factor: 3.396

4.  Amino acid uptake in arterio-venous serum of normal and cancerous colon tissues.

Authors:  Lin-Bo Wang; Jian-Guo Shen; Su-Zhan Zhang; Ke-Feng Ding; Shu Zheng
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

5.  Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.

Authors:  Carolina Campos Lima Moreira; Priscila Cassolla; Ana Paula Segantini Dornellas; Hely de Morais; Camila Oliveira de Souza; Glaucia Regina Borba-Murad; Roberto Barbosa Bazotte; Helenir Medri de Souza
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

6.  Antiproliferative role of Indigofera aspalathoides on 20 methylcholanthrene induced fibrosarcoma in rats.

Authors:  Sivagnanam Selva Kumar; Mudiganti Ram Krishna Rao; Maruthaiveeran Periyasamy Balasubramanian
Journal:  Asian Pac J Trop Biomed       Date:  2012-12

7.  Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine.

Authors:  R Kinscherf; V Hack; T Fischbach; B Friedmann; C Weiss; L Edler; P Bärtsch; W Dröge
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

8.  Glucose turnover and recycling in colorectal carcinoma.

Authors:  W A Kokal; A McCulloch; P D Wright; I D Johnston
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

9.  Metabolic substrate utilization by tumour and host tissues in cancer cachexia.

Authors:  H D Mulligan; M J Tisdale
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

10.  Tissue-specific effects of rapid tumour growth on lipid metabolism in the rat during lactation and on litter removal.

Authors:  R D Evans; D H Williamson
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.